|Description||AM095, an effective LPA1 receptor antagonist, has been found to decrease dermal fibrosis caused by attenuates bleomycin. IC50: 0.98 uM and 0.73 uM for human and mouse LPA1 respectively.|
|Synonyms||AM095 (free acid); CHEMBL2182052; AM095; AM-095 (free base); AM 095 (parent compound)|
|Solubility||DMSO: ≥ 67.3 mg/mL|
|Application||AM095 is an effective LPA1 receptor antagonist that has been found to decrease dermal fibrosis caused by attenuates bleomycin.|
|Shelf Life||As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly|
Sphingosine-1-phosphate is an endogenous second messenger that inhibits cell proliferation and motility, and Ca2+ mobilization to prevent tumor cell metastasis....
The modulator of sphingosine-1-phosphate receptor
Fingolimod, a derivative of the fungal metabolite myriocin, is an antagonist of S1P (IC50 of 0.033 nM) which is an extracellular lipid mediator. Fingolimod has ...
1-Oleoyl lysophosphatidic acid sodium sa
1-Oleoyl lysophosphatidic acid sodium salt is lysophospholipid receptor (LPA1 and LPA2) agonist. It can inhibit differentiation of neural stem cells into neuron...
S1P1 Agonist III
S1P1 Agonist III, a S1P1 agonist, has been found to induce the lymphocyte counts' reduction in circulating blood and have potentials in study of autoimmune dise...
Ex 26 is a potent and selective S1P1 receptor antagonist (IC50 = 0.93 nM) with > 3,000-fold selectivity over S1P2, S1P3, S1P4 and S1P5. It causes lymphocyte seq...
W146 is a potent and selective sphingosine-1-phosphate receptor (S1P1) antagonist (Ki = 18 nM) with no effect at S1P2, S1P3 or S1P5. W146 potentiates capillary ...
TC-SP 14 is a potent and selective S1P1 agonist (EC50 = 0.042 and 3.47 μM for human S1P1 and S1P3, respectively). TC-SP 14 attenuates immune response to antigen...